Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myxoid liposarcoma. Experience with chemotherapy

S R Patel1, M A Burgess, C Plager

  • 1Department of Melanoma/Sarcoma Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030.

Cancer
|August 15, 1994
PubMed
Summary

Doxorubicin- and dacarbazine-based chemotherapy shows effectiveness in treating myxoid liposarcoma (ML), a common cancer. This treatment approach yielded objective responses in 44% of evaluable patients with ML.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-precision measurement of the <i>W</i> boson mass with the CDF II detector.

Science (New York, N.Y.)·2022
Same author

Search for the Exotic Meson X(5568) with the Collider Detector at Fermilab.

Physical review letters·2018
Same author

Combined Forward-Backward Asymmetry Measurements in Top-Antitop Quark Production at the Tevatron.

Physical review letters·2018
Same author

Tevatron Combination of Single-Top-Quark Cross Sections and Determination of the Magnitude of the Cabibbo-Kobayashi-Maskawa Matrix Element V_{tb}.

Physical review letters·2015
Same author

Search for Resonances Decaying to Top and Bottom Quarks with the CDF Experiment.

Physical review letters·2015
Same author

Tevatron constraints on models of the Higgs boson with exotic spin and parity using decays to bottom-antibottom quark pairs.

Physical review letters·2015

Area of Science:

  • Oncology
  • Medical Research
  • Cancer Treatment

Background:

  • Myxoid liposarcoma (ML) is the most common liposarcoma subtype.
  • Classified as intermediate grade with metastatic potential, its chemotherapy sensitivity is poorly understood.

Purpose of the Study:

  • To evaluate the efficacy of chemotherapy in patients with myxoid liposarcoma.
  • To analyze treatment outcomes based on a retrospective review of patient data.

Main Methods:

  • Retrospective review of 44 patients with histologically confirmed ML from 1986-1992.
  • Analysis of 21 patients treated with chemotherapy, focusing on doxorubicin- and dacarbazine-based regimens.

Main Results:

  • Of 18 evaluable patients receiving doxorubicin- and dacarbazine-based chemotherapy, 8 (44%) achieved an objective response.

Related Experiment Videos

  • Chemotherapy was administered in neoadjuvant, recurrent/metastatic, and postoperative settings.
  • Follow-up data indicated varying survival outcomes, with some patients alive with no evidence of disease.

    • Conclusions:

    • Doxorubicin- and dacarbazine-based chemotherapy is an effective treatment modality for myxoid liposarcoma.
    • The findings support the use of this regimen in managing ML.